Certain Common Shares of PharmaEssentia Corporation are subject to a Lock-Up Agreement Ending on 18-JUL-2023. These Common Shares will be under lockup for 91 days starting from 18-APR-2023 to 18-JUL-2023.

Details:
The company have agreed that, subject to certain exceptions, from the date hereof and until 90 days after the Closing Date, Certain of shareholders and directors will not, without the prior written consent of the Initial Purchasers, lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to (1) swap or other agreements that transfer to another, in whole or in part, any of the economic consequences of ownership of the Shares, the GDSs or any equity securities (the ?Equity Securities?) of the Company or (2) cash settlement or otherwise) by the Company or any of its Affiliate or any person in privity with the Company or any of its Affiliate) directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, and the rules and regulations of the Commission promulgated thereunder, with respect to, or announce the offering of, any Shares, GDSs or Equity Securities or any securities convertible into, or exchangeable for, the Shares, the GDSs or the Equity Securities. See ?Plan of Distribution?.